Drug Shortage Report for PORTIA 21
Report ID | 126530 |
Drug Identification Number | 02295946 |
Brand name | PORTIA 21 |
Common or Proper name | PORTIA TABS 0.15/0.03MG BLISTER 21 |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | LEVONORGESTREL ETHINYL ESTRADIOL |
Strength(s) | 0.15MG 0.03MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 21 |
ATC code | G03AA |
ATC description | HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2020-10-14 |
Estimated end date | 2021-02-28 |
Actual end date | 2020-11-25 |
Shortage status | Resolved |
Updated date | 2020-11-26 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2020-11-26 | French | Compare |
v5 | 2020-11-26 | English | Compare |
v4 | 2020-11-12 | French | Compare |
v3 | 2020-11-12 | English | Compare |
v2 | 2020-10-15 | French | Compare |
v1 | 2020-10-15 | English | Compare |
Showing 1 to 6 of 6